Carcinoid Tumor

被引:2
作者
Chowsanitphon, Joyce [1 ]
机构
[1] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA
关键词
NEUROENDOCRINE TUMORS; PHASE-II; OCTREOTIDE;
D O I
10.1188/10.ONF.677-679
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:677 / 679
页数:3
相关论文
共 10 条
[1]  
*AM CANC SOC, 2010, GASTR CARC TUM WHAT
[2]  
BENSON AB, 2007, CANC MANAGEMENT MULT, P287
[3]   Activity of sunitinib in patients with advanced neuroendocrine tumors [J].
Kulke, Matthew H. ;
Lenz, Heinz-Josef ;
Meropol, Neal J. ;
Posey, James ;
Ryan, David P. ;
Picus, Joel ;
Bergsland, Emily ;
Stuart, Keith ;
Tye, Lesley ;
Huang, Xin ;
Li, Jim Z. ;
Baum, Charles M. ;
Fuchs, Charles S. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) :3403-3410
[4]  
*NAT COMPR CANC NE, 2010, NCOV CLIN PRACT GUID
[5]  
Parra Isabel, 2002, Can Respir J, V9, P215
[6]   Carcinoid Tumors [J].
Pinchot, Scott N. ;
Holen, Kyle ;
Sippel, Rebecca S. ;
Chen, Herbert .
ONCOLOGIST, 2008, 13 (12) :1255-1269
[7]   Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group [J].
Rinke, Anja ;
Mueller, Hans-Helge ;
Schade-Brittinger, Carmen ;
Klose, Klaus-Jochen ;
Barth, Peter ;
Wied, Matthias ;
Mayer, Christina ;
Aminossadati, Behnaz ;
Pape, Ulrich-Frank ;
Blaeker, Michael ;
Harder, Jan ;
Arnold, Christian ;
Gress, Thomas ;
Arnold, Rudolf .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4656-4663
[8]   Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: Results of a phase II study [J].
Yao, James C. ;
Phan, Alexandria T. ;
Chang, David Z. ;
Wolff, Robert A. ;
Hess, Kenneth ;
Gupta, Sanjay ;
Jacobs, Carmen ;
Mares, Jeannette E. ;
Landgraf, Andrea N. ;
Rashid, Asif ;
Meric-Bernstam, Funda .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4311-4318
[9]   Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b [J].
Yao, James C. ;
Phan, Alexandria ;
Hoff, Paulo M. ;
Chen, Helen X. ;
Charnsangavej, Chusilp ;
Yeung, Sai-Ching J. ;
Hess, Kenneth ;
Ng, Chaan ;
Abbruzzese, James L. ;
Ajani, Jaffer A. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) :1316-1323
[10]   Metastatic carcinoid tumors: A clinical review [J].
Zuetenhorst, JM ;
Taal, BG .
ONCOLOGIST, 2005, 10 (02) :123-131